Advertisement
Turtle Cameron, Spyre Therapeutics CEO, sells $739k in shares
Business

Turtle Cameron, Spyre Therapeutics CEO, sells $739k in shares

April 4, 2026
Investing.com
Scroll
Turtle Cameron, Spyre Therapeutics CEO, sells $739k in shares
Read Full Article
Investing.com
Investing.com

Coverage and analysis from Israel. All insights are generated by our AI narrative analysis engine.

Israel
Bias: center
Advertisement
You might also like

Explore More